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 27 
ABSTRACT 28 
The repeating subunit of chromatin, the nucleosome, includes two copies of each of the 29 
four core histones, and several recent studies have reported that asymmetrically-30 
modified nucleosomes occur at regulatory elements in vivo. To probe the mechanisms 31 
by which histone modifications are read out, we designed an obligate pair of H3 32 
heterodimers, termed H3X and H3Y, which we extensively validated genetically and 33 
biochemically. Comparing the effects of asymmetric histone tail point mutants with those 34 
of symmetric double mutants revealed that a single methylated H3K36 per nucleosome 35 
was sufficient to silence cryptic transcription in vivo. We also demonstrate the utility of 36 
this system for analysis of histone modification crosstalk, using mass spectrometry to 37 
separately identify modifications on each H3 molecule within asymmetric nucleosomes. 38 
The ability to generate asymmetric nucleosomes in vivo and in vitro provides a powerful 39 
and generalizable tool to probe the mechanisms by which H3 tails are read out by 40 
effector proteins in the cell. 41 
 42 
 43 
INTRODUCTION 44 
Packaging of eukaryotic genomes into chromatin has widespread consequences for 45 
genomic function, as nucleosomes generally impede the access of proteins to the 46 
underlying DNA (1). In addition, the histone proteins are subject to a huge variety of 47 
covalent modifications, which affect genomic function in ways ranging from direct 48 
alterations in the biophysical nature of the chromatin fiber to recruitment or activation of 49 
various regulatory proteins. 50 
The histone octamer is comprised of two copies of each of the four histones H2A, 51 
H2B, H3, and H4, organized with two H2A/H2B dimers associated with a central core 52 
tetramer of histone H3 and H4 (2). The symmetry inherent to the histone octamer has 53 
long been appreciated, and it has been suggested that chromatin function may be 54 
regulated at the level of histone modification symmetry – that K4me3/K4me0 and 55 
K4me3/K4me3 nucleosomes might serve distinct functions in vivo, for example. Indeed, 56 
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increasing evidence supports the existence of asymmetrically-modified nucleosomes in 57 
vivo. In mammals, immunopurification and mass spectrometry of nucleosomes marked 58 
with H3K27me3 revealed a mixture of symmetrically-modified nucleosomes as well as 59 
asymmetric nucleosomes modified on only one H3 tail (3). More recent single molecule 60 
studies of H3K4me3/K27me3-marked “bivalent” nucleosomes reveal that the vast 61 
majority of these nucleosomes are asymmetrically modified, with each H3 tail bearing 62 
one of the two methylation marks, rather than both marks co-occurring on the same H3 63 
molecule (4). In budding yeast, ChIP-Exo and chemical mapping studies identified a 64 
subset of nucleosomes that exhibit asymmetric contacts with the underlying genomic 65 
DNA (5, 6), suggested to reflect histone octamers associated with an asymmetrically-66 
localized DNA bulge. 67 
While evidence therefore increasingly supports the hypothesis that nucleosomes 68 
across the genome – particularly at regulatory regions – can be modified 69 
asymmetrically, at present it is largely unknown whether nucleosome symmetry affects 70 
genomic functions such as transcription. For instance, do any chromatin regulators bind 71 
specifically to singly-modified nucleosomes, or to doubly-modified nucleosomes? A 72 
handful of studies in vitro have suggested that chromatin regulators can distinguish 73 
singly-modified from doubly-modified nucleosomes. For instance, Li et al assembled 74 
and purified asymmetric nucleosomes lacking a single H3 tail in vitro, subsequently 75 
showing that the histone acetyltransferase Gcn5 exhibited cooperative binding to two 76 
histone tails (7, 8). Conversely, asymmetrically H3K4-methylated nucleosomes were, 77 
like unmodified nucleosomes, efficiently methylated at K27 by the PRC2 complex, 78 
whereas this methylation was inhibited by the presence of symmetric H3K4me3 marks 79 
(3). Although these in vitro studies generate hypotheses for how chromatin effectors 80 
might be affected by nucleosome symmetry in the cell, the inherent symmetry of the 81 
natural H3-H3 interface has made in vivo tests of these hypotheses impossible until 82 
now. 83 
Here, we develop a novel system to enable analysis of the functional 84 
consequences of nucleosome symmetry in vivo. Using rational design, followed by in 85 
vivo optimization and selection, we developed a pair of H3 proteins – H3X and H3Y – 86 
that form heterodimers in vivo, yet cannot homodimerize. We validated this system 87 
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genetically and biochemically in budding yeast, confirming that the vast majority of 88 
histone octamers in the cell contain a heterodimeric H3X/H3Y at their core. 89 
Furthermore, we confirm that the engineered specificities are recapitulated in vitro 90 
during biochemical reconstitution of histone octamers with recombinant subunits. We 91 
then used this system to probe several mechanistic aspects of nucleosome function in 92 
vivo, finding that a single copy of H3K36 is sufficient for stress resistance, and to silence 93 
cryptic transcription, in vivo. In addition, we show that disruption of H3S10 affects H3K9 94 
acetylation only on the same tail, demonstrating the utility of this approach for 95 
interrogating histone “crosstalk”. This system thus represents a powerful approach to 96 
mechanistically probe the role of histone stoichiometry and symmetry in a variety of 97 
aspects of chromatin biology. 98 
 99 
 100 
RESULTS 101 
Design and validation of obligate heterodimers 102 
The histone octamer is built on a central core tetramer of histone H3 and H4, 103 
assembled around a central H3-H3 homodimeric interface (9). In order to develop a 104 
system to analyze the role of nucleosome symmetry in chromatin regulation in vivo, we 105 
set out to design a pair of H3 molecules – “H3X” and “H3Y” – which cannot form X/X or 106 
Y/Y homodimers, but will efficiently form H3X/H3Y heterodimers (Figure 1A). We 107 
initially used protein design to develop six sets of H3 mutants that are predicted to have 108 
much higher affinity with a paired mutant protein than with wild-type H3. Each 109 
engineered variant has “bumps and holes” that are also predicted to reduce the 110 
potential for homodimerization. We focused our efforts on the hydrophobic cluster 111 
formed by amino acids L109, A110, L126, and L130 (Figure 1B) in the nucleosome 112 
structure (pdb 1kx3). At these positions, sequence and conformational space were 113 
enumerated using a rotamer description of side chain geometry and a molecular 114 
mechanics force-field (10) to generate a pairwise energy matrix. We used a previously 115 
described algorithm (11) to identify sequences that preferentially energetically partition 116 
as heterodimers.  117 
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We then carried out genetic tests of six initial designs in vivo, reasoning that 118 
budding yeast carrying both H3X and H3Y should be viable, but yeast carrying H3X 119 
alone or H3Y alone would be inviable due to the failure of these H3 molecules to 120 
homodimerize. In our initial tests, one of the original six designs (H3X = L126V, L130V; 121 
H3Y= L109I, A110W, L130I) exhibited most of the expected growth behaviors. 122 
However, although yeast carrying H3Y alone exhibited no growth even after 21 days of 123 
culture (Figure 1C and not shown), H3X-only strains did grow even in the absence of 124 
H3Y, albeit poorly – colonies were only observed after nine or more days of growth of 125 
these strains (Figure 1 – Figure Supplement 1A), in contrast to the abundant colonies 126 
observed for H3X/H3Y strains after just two or three days. As homodimerization of H3X 127 
even at low levels could complicate interpretation of this system, we carried out a round 128 
of in vivo selection to optimize the H3X interface (Figure 1 – Figure Supplement 1B-129 
C). We randomized each of the H3/H3 interface residues on the backbone of the initial 130 
H3X gene, generating libraries of yeast strains bearing these mutant “H3X*” molecules 131 
paired with our previously-selected H3Y design. Strains that grew robustly with 132 
H3X*/H3Y pairs were then re-tested for growth in the absence of the H3Y. In this 133 
manner, we identified four final versions of H3X (named 126A, 130A, 130T, and 130Q 134 
for the additional substitutions on the original H3X backbone) that reproducibly 135 
conferred robust growth in the presence of H3Y but were completely inviable in its 136 
absence (Figure 1D-E). We obtained multiple isolates encoding each of these amino 137 
acid substitutions (13, 5, 5, and 5, respectively), suggesting that we had adequately 138 
surveyed the possible codons. Consistent with our observation that these residues are 139 
sensitive points for H3/H3 dimeric interactions, L126A and L130A mutations cause 140 
lethality when present on symmetric H3 molecules (12). 141 
Although these genetic tests suggest that H3X or H3Y alone do not 142 
homodimerize efficiently enough to support growth, the possibility remains that in the 143 
context of cells expressing both H3X and H3Y there could nonetheless exist a 144 
substantial fraction of inappropriate homodimeric interactions, which would complicate 145 
interpretation of downstream results. To quantitatively determine the extent of X/X or 146 
Y/Y homodimerization in vivo, a biotin-tagged (13) H3X or Y variant was coexpressed in 147 
combination with two other H3s: the same variant with a different epitope tag, and the 148 
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designed partner (Figure 2). To analyze H3-H3 interactions within individual 149 
nucleosomes and avoid contamination from adjacent nucleosomes (as could arise from 150 
undigested dinucleosomes), we treated extracts from these cells with dimethyl 151 
suberimidate (DMS), a crosslinking agent that produces well-characterized crosslinks 152 
within histone octamers (14, 15). Crosslinked samples were then digested with 153 
micrococcal nuclease to generate a soluble population of mononucleosomes. This was 154 
followed by biotin-based affinity purification in the presence of high salt (2M NaCl) to 155 
remove DNA and adjacent nucleosomes, leaving only crosslinked protein complexes 156 
that were subsequently analyzed by Western blotting. The DMS crosslinking efficiency 157 
of the X-Y heterodimeric pairs was nearly identical to that observed in cells expressing 158 
tagged H3 variants with a wild-type, homodimeric interface (Figure 2 – Figure 159 
Supplement 1). 160 
Using this assay, we analyzed the extent of homodimerization of a lead H3X 161 
candidate using strains expressing Biotin-H3X, V5-H3X, and Myc-H3Y (Figure 2A-C). 162 
After streptavidin purification of biotin-H3X from DMS-crosslinked yeast, the species 163 
migrating at 31kD (red arrow, Figure 2B) is comprised of the captured biotin-H3X 164 
crosslinked to the other H3 from the same nucleosome. Myc-H3Y molecules were 165 
abundantly detected in the crosslinked 31kD species (Figure 2B, Figure 2 – Figure 166 
Supplement 2), consistent with the expected heterodimerization with H3X. In contrast, 167 
barely detectable levels of V5-H3X – which would result from H3X-H3X 168 
homodimerization – were observed in the bound 31kD species (Figure 2B, quantitated 169 
in Figure 2C). In a reciprocal experiment, we assayed H3Y homodimerization, again 170 
finding efficient heterodimerization in vivo along with barely detectable H3Y 171 
homodimerization (Figure 2D-F, Figure 2 – Figure Supplement 2). 172 
In addition to its utility for genetic analysis of nucleosome symmetry, the ability to 173 
generate asymmetric nucleosomes in vitro would also provide a valuable resource for 174 
biochemical and structural studies. We therefore purified recombinant human histones 175 
H2A, H2B, and H4, as well as recombinant H3X and H3Y variants engineered onto the 176 
human H3 histone backbone. Gel filtration of in vitro assembled octamers revealed 177 
robust assembly of histone octamers assembled using wild-type H3, or assembled 178 
around the H3X/H3Y heterodimer pair. In contrast, attempts to refold histone octamers 179 
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using H3X only or H3Y only resulted in high molecular weight aggregates with no 180 
functional histone octamer (Figure 3, Figure 3 – Figure Supplement 1A-B). Moreover, 181 
H3X/H3Y-based octamers were readily reconstituted into nucleosomes when 182 
assembled with DNA, whereas the material obtained from H3X alone or H3Y alone did 183 
not assemble into nucleosomes. 184 
In addition to the ability to generate asymmetric nucleosomes from recombinant 185 
proteins in vitro, chromatin purified from mutant yeast strains has also proven to be a 186 
powerful tool for in vitro chromatin studies (see, eg, (16)). We therefore affinity-purified 187 
chromatin from strains expressing an asymmetric H3X/H3Y pair in which one H3 carries 188 
a biotin tag, readily recovering the core histones regardless of whether the biotin tag 189 
was present on the X or Y variant (Figure 3 – Figure Supplement 1C). The engineered 190 
H3X/H3Y interface thus enables the convenient generation of asymmetric nucleosomes 191 
for biophysical and biochemical studies of nucleosomal symmetry in vitro. 192 
Taken together, our genetic and biochemical analyses validate our designed 193 
obligate heterodimers, indicating that the great majority (average of ~97% as measured 194 
in Figure 2C,F) if not all of the nucleosomes in vivo are indeed heterodimeric. We have 195 
therefore established a unique system for manipulation of nucleosomal symmetry in 196 
vivo and in vitro. As with all studies based on expression of mutant histones, the mutant 197 
nucleosomes will be located throughout the yeast genome. Nonetheless, such studies 198 
have provided great insights into chromatin function over decades of study (12, 17), 199 
distinguishing between genes whose expression requires a given histone residue and 200 
those genes that are unaffected despite the loss of the residue (and its modification, if 201 
present). 202 
 203 
Genetic analysis of interactions between histone tail mutations 204 
The ability to generate asymmetric nucleosomes in vivo enabled us to quantitatively 205 
characterize interactions between mutations on the two histone tails using genetic 206 
epistasis. To this end, we generated “trios” of histone point mutants – asymmetric single 207 
mutations H3Xwt/H3Ymut and H3Xmut/H3Ywt, and the double mutation 208 
H3Xmut/H3Ymut. Importantly, although strains expressing the heterodimeric X/Y H3s 209 
exhibit reduced growth in YPD (doubling times of ~ 240 minutes at 30oC compared to 210 
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~140 minutes for the parent strain, Figure 4 – Figure Supplement 1A) and a modest 211 
temperature-sensitive phenotype (robust growth at 34 C but failure to grow at 37 C – 212 
see below), any effects of the mutant X/Y interface on chromatin regulation and cellular 213 
function are internally controlled for in all studies by comparing all yeast carrying single 214 
or double histone mutations to the “pseudo-wild type” strain (H3Xwt/H3Ywt).  215 
To broadly survey the landscape of inter-tail epistasis between histone 216 
mutations, we generated a set of 12 mutant trios, focusing on relatively well-217 
characterized sites of post-translational covalent modifications. Mutant effects on 218 
organismal phenotypes are often context-dependent, and stress conditions can provide 219 
a sensitized environment for detection of chromatin-related phenotypes (18). We first 220 
assayed the relative fitness of these strains in both low (0.2 M) and high (0.8 M) KCl-221 
containing media (Figure 4A), as the osmotic stress response is one of the most 222 
commonly studied transcriptional responses in budding yeast (19, 20). As expected, 223 
growth rates for strains carrying a single mutation on H3X were generally well-224 
correlated with those for H3Y mutants, although a small subset of mutations exhibited 225 
different behavior on different H3 backbones (see, eg, H3K37Q in 0.8M KCl).  226 
Consistent with the often-subtle phenotypes resulting from histone point 227 
mutations, the majority of mutations examined conferred no significant growth defects 228 
under either growth condition, or subtle growth effects such as the enhanced growth 229 
observed in all three H3K18Q strains growing in high salt. In contrast, we noted 230 
significantly diminished growth, particularly in high salt, for yeast carrying double 231 
H3K14R, H3K14Q, or H3K36Q mutations (Figure 4B, Figure 4 – Figure Supplement 232 
1B). Interestingly, the behaviors of the corresponding asymmetric single mutants were 233 
distinct: for H3K14R, single mutants already exhibited a partial growth defect that was 234 
exacerbated in the double mutant, while for H3K36Q the single mutant strains had no 235 
measurable deficit compared to the pseudo-wild type. These growth phenotypes 236 
correspond roughly to additive and recessive epistasis, respectively. Importantly, the 237 
stress sensitivity observed for these mutants was not specific to osmotic stress. 238 
Consistent with prior studies demonstrating that yeast lacking H3K36 methylation are 239 
hypersensitive to DNA damaging agents (21), we find that the K36Q double mutants – 240 
but neither of the single K36Q mutants – displayed increased sensitivity to both the 241 
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DNA alkylating agent methyl methanesulfonate (MMS) and the strand break-inducing 242 
agent phleomycin (Figure 4C). Moreover, these mutants were also temperature-243 
sensitive, as symmetric double mutants exhibited reduced growth at 34 C, while the 244 
asymmetric mutants exhibited similar or only slightly reduced growth compared to the 245 
pseudo-wild type under these conditions (Figure 4D, Figure 4 – Figure Supplement 246 
2). We conclude that K36Q mutations confer sensitivity to osmotic, temperature and 247 
DNA damage stresses, but only when symmetrically present on nucleosomes. These 248 
data support the biochemical data indicating that we can separately manipulate single 249 
H3 molecules within nucleosomes in vivo, and provide an illustration of the types of 250 
biological regulation that can be discovered using these tools.  251 
 252 
A single H3K36 suffices to silence cryptic internal promoters 253 
Our growth data that a single copy of H3K36 per nucleosome is sufficient to support 254 
growth under stress conditions. What is the mechanistic basis for this function? In 255 
principle, mutation of this lysine could 1) affect biophysical properties of the nucleosome 256 
by eliminating a positive charge, 2) disrupt a binding site for regulatory protein that binds 257 
to the unmodified tail, or 3) disrupt (or mimic) a modification-dependent regulatory event 258 
(22). H3K36 is methylated by Set2 (23), with the resulting modified residues serving to 259 
activate the RPD3S histone deacetylase complex via binding of the Eaf3 260 
chromodomain-containing subunit (24-28). As the major biological role served by 261 
H3K36 methylation is silencing of cryptic internal promoters via activation of the RPD3S 262 
complex (24), and given that RPD3S can bind to nucleosomes with a single H3K36me3 263 
modification (29), we sought to test whether a single methylated H3K36 per nucleosome 264 
would be sufficient to support robust silencing of such cryptic transcripts in vivo. 265 
We first explored this idea with genetic tests, comparing the growth phenotypes 266 
of a P38V mutant series to K36Q mutants. The P38V mutants enable di- and tri-267 
methylation of H3K36 to be distinguished – the wild-type proline residue at this position 268 
undergoes regulated isomerization, and P38V mutations that eliminate the possibility of 269 
proline isomerization block trimethylation (30) but not dimethylation (31) of the nearby 270 
K36 residue, a finding that we confirm here (Figure 4 – Figure Supplement 3). 271 
Importantly, cells expressing only H3P38V display none of the cryptic transcription 272 
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phenotypes observed in set2, eaf3, or H3K36Q mutants ((31) and see below), indicating 273 
that H3K36me2 is sufficient for the proper activation of the Rpd3S complex with regards 274 
to repression of cryptic transcription. Consistent with this, we find that double P38V 275 
mutations, on either a wild-type H3 backbone or in the context of the XY system, did not 276 
cause the temperature sensitivity observed in K36Q mutant cells (Figure 4E, Figure 4 – 277 
Figure Supplement 2). We therefore hypothesized that a single H3 N-terminal tail 278 
bearing K36 di- or trimethylation is sufficient to repress cryptic transcription.  279 
To determine whether the single methylated K36 must be trimethylated or 280 
whether dimethylation is sufficient, we generated strains carrying the K36Q and P38V 281 
mutations in a trans conformation, that is, on opposite H3 N-termini (Figure 4F). 282 
Consistent with previous analyses of the effects of P38V (30, 31), immunoblotting 283 
confirms that these strains have one H3 tail (K36Q) that lacks K36 methylation entirely, 284 
and one tail (P38V) with a dimethylated K36 residue (Figure 4 – Figure Supplement 285 
3). We made strains with both possible configurations: H3XK36Q + H3YP38V and 286 
H3XP38V + H3YK36Q. Notably, neither of these K36Q/P38V trans strains are sensitive 287 
to growth at 34C (Figure 4F) or DNA damaging agents (Figure 4C). Thus, they 288 
phenotypically resemble the P38V double mutants and the single K36Q mutants, rather 289 
than the temperature-sensitive K36Q double mutants. These data indicate that a single 290 
K36me2 is sufficient to promote stress tolerance in budding yeast. 291 
To determine whether the growth data reflect underlying defects in control of 292 
cryptic transcription, we carried out Northern blots against a canonical target of this 293 
pathway – STE11 – which is host to a well-characterized cryptic promoter that is 294 
silenced in a K36- and RPD3S-dependent manner (24, 25l, 26). First, we confirmed the 295 
expected increase in cryptic transcription in eaf3 mutants, and in yeast carrying 296 
symmetric H3K36Q mutations on the wild-type H3 backbone (Figures 5A-B, lanes 1-4, 297 
10). In addition, we confirm that H3K36me2 was sufficient to silence the STE11 cryptic 298 
promoter, as H3P38V mutants (which lack H3K36me3 but exhibit normal H3K36me2 299 
levels) did not cause significantly increased cryptic transcription (lane 5). 300 
Turning next to the question of whether one H3K36 is sufficient for silencing, we 301 
analyzed STE11 RNAs in single and double H3K36Q mutants in the H3X/Y backbone 302 
(Figure 5, lanes 6-9). Consistent with the growth phenotypes observed in Figure 4, we 303 
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find that the pseudo-wildtype H3X/Y cells and the cells with a single K36Q mutated tail 304 
display similar, low levels of cryptic transcripts (lanes 6-8). In contrast, the cells with two 305 
K36Q mutated tails display greatly elevated cryptic transcript levels (lane 9). As 306 
expected, neither single nor double P38V mutant tails affected cryptic transcription in 307 
our strain background (lanes 14-16). Finally, P38V/K36Q trans strains (lanes 17-18) 308 
displayed modest derepression of cryptic transcription, more similar to that observed in 309 
single K36Q mutant cells (lanes 7-8) than the high level observed in K36Q double 310 
mutants (lane 9). We confirmed the generality of these findings using another well-311 
studied model for cryptic transcription, the FLO8 locus (32), where derepression of 312 
cryptic transcription was again observed specifically in the K36Q double mutant, but not 313 
in either K36Q single mutant (Figure 5 – Figure Supplement 1). We conclude that a 314 
single K36-di-methylated H3 tail per nucleosome is sufficient to restrain cryptic 315 
transcription in vivo.  316 
 317 
Interrogating histone crosstalk in cis and trans  318 
In addition to our ability to uncover effects of asymmetric mutant nucleosomes on 319 
transcriptional regulation, our system also provides a unique opportunity to determine 320 
whether histone “crosstalk” – the ability of one histone modification to alter the level of 321 
another modification via effects on modifying enzyme recruitment or activity (33) – 322 
occurs in cis (on the same histone), or in trans. We generated biotin-tagged H3 323 
molecules either carrying a point mutation of interest in cis, or carrying an otherwise 324 
wild-type sequence on the biotin-tagged H3, paired with a point mutation in trans 325 
(Figure 6A, cartoon). Biotin-tagged H3 molecules were then purified under stringent, 326 
partially denaturing conditions to facilitate the separation of H3X and H3Y, and the 327 
biotin-tagged H3 was subject to mass spectrometry to identify histone modifications 328 
present. Analysis of peptides derived from the engineered H3X/H3Y interface confirmed 329 
our ability to efficiently purify the biotin-tagged H3 molecule away from the untagged H3 330 
molecule from each nucleosome, with >93% purity observed for informative peptides 331 
analyzed (Figure 6A). 332 
As cases of histone crosstalk that occur between different histones (e.g. effects 333 
of H2B ubiquitylation on H3 methylation levels) cannot be interrogated using our 334 
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system, we focused on H3S10, whose phosphorylation affects histone H3 lysine 335 
acetylation (34, 35). We found that the fraction of H3 molecules acetylated at K9 was 336 
lower in yeast strains carrying H3S10A symmetrically, either on a wild-type histone 337 
backbone or in the H3X/H3Y system. This decrease was observed by mass spec, and 338 
confirmed by quantitative Western blot (Figures 6B and C, left panel). Turning next to 339 
analysis of asymmetric mutant nucleosomes, mass spectrometric analyses showed that 340 
H3K9 acetylation levels were significantly decreased on the same histone tail carrying 341 
the S10A mutation, but were not affected by the presence of H3S10A in trans (Figure 342 
6B). Western blotting for H3K9ac in yeast strains where an epitope tag allows H3X and 343 
H3Y isoforms to be separated by gel electrophoresis confirmed our mass spec-based 344 
analysis of histone acetylation, with H3S10A affecting adjacent H3K9 acetylation on the 345 
same tail, but having no effect on modification of a paired wild-type H3 tail (Figures 6C-346 
F). 347 
 348 
 349 
 350 
DISCUSSION 351 
Here, we demonstrate a novel system enabling genetically-encoded symmetry breaking 352 
for the histone octamer. Using protein engineering and directed evolution, we have 353 
designed and validated a pair of H3 variants – H3X and H3Y – that efficiently 354 
heterodimerize with one another in vivo, but which form extremely low levels (<3%) of 355 
homodimers. The ability to generate nucleosomes bearing either single mutations or 356 
symmetric double mutations to key regulatory residues will allow detailed mechanistic 357 
analyses of the roles for histone modifications in various aspects of chromosome 358 
biology. Here, we demonstrate two of many potential uses of this system, interrogating 359 
the role for H3K36 in control of cryptic transcription, and investigating “crosstalk” 360 
between histone modifications.  361 
 362 
Interpreting epistasis between the histone tails 363 
To genetically interrogate interactions between the histone tails, we analyzed 364 
phenotypes in yeast strains carrying one of four nucleosomes: H3Xwt/H3Ywt – “pseudo-365 
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wild-type” – and H3Xmut/H3Ywt, H3Xwt/H3Ymut, and H3Xmut/H3Ymut. In principle, 366 
we could expect to see a variety of classes of interactions between the mutations, 367 
including transgressive epistasis (not observed in this study), and a range from 368 
dominant epistasis, in which the single mutants exhibit the same phenotype observed in 369 
the double mutant, to recessive epistasis, in which a given phenotype is only observed 370 
in the double. For quantitative traits, these correspond to alleviating and aggravating 371 
epistasis, respectively (36). 372 
 Measured in the context of obligate heterodimers, such genetic interactions can 373 
provide insights into the mechanistic basis for readout of histone modifications. As a 374 
simple example, a protein that binds cooperatively to both tails of a given nucleosome 375 
should give rise to dominant epistasis between the histone mutations that affect its 376 
binding (depending of course on the concentration of the factor in question and its Kd 377 
for a single tail), as loss of a single residue abrogates the cooperative binding. 378 
Conversely, if each histone tail recruits a binding protein independently of the other, 379 
then loss of a single tail could have a range of quantitative effects on local gene 380 
expression, depending on whether or not the binder is typically recruited in excess for 381 
some function. Downstream of initial binding interactions, many readouts of histone 382 
modification function, such as mRNA abundance, are several mechanistic steps 383 
removed from direct binding, and thus more complex models can readily be envisioned 384 
that would exhibit a range of distinct epistasis behaviors depending on the input/output 385 
relationships for the various intervening steps. 386 
 Here, we surveyed intra-tail epistasis for 12 sets of H3 point mutants, simply 387 
using growth rate as a phenotype. Even with this coarse resolution, we identified inter-388 
tail interactions including dominant epistasis (for the enhanced low-salt growth seen in 389 
H3K18Q mutants, for example) to relatively unusual cases of recessive epistasis (for 390 
H3K36Q effects on growth in stress conditions). For followup studies we focused on 391 
H3K36Q, given that recessive epistasis makes more concrete mechanistic predictions, 392 
and given the well-understood role for H3K36 modification in gene regulation. 393 
 394 
A single H3K36me2 per nucleosome is sufficient for stress resistance and 395 
repression of cryptic transcripts 396 
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Although H3K36 is potentially subject to multiple distinct modification pathways – 397 
H3K36 is acetylated at a small fraction of nucleosomes (37), for example – the majority 398 
of phenotypes of H3K36 mutants result from loss of H3K36 methylation-dependent 399 
activity of the RPD3S complex (24, 25l, 26). Our system allowed us to ask, essentially, 400 
whether a single RPD3S binding site per nucleosome is sufficient to repress cryptic 401 
internal promoters. 402 
 Several lines of evidence demonstrate that a single H3K36me2 is sufficient for 403 
RPD3S silencing at cryptic promoters. First, we find that H3K36Q significantly affects 404 
growth rate – particularly under stress conditions – only when present in both H3 copies 405 
per nucleosome. Next, consistent with a primary function of H3K36 modification being to 406 
repress cryptic intragenic promoters, we show that a single wild-type K36 is sufficient to 407 
prevent transcription at such promoters. Third, extending prior studies, we find that 408 
growth rate and cryptic promoter silencing are both unaffected by double P38V mutants. 409 
P38V inhibits trimethylation but not dimethylation of K36 residues (31), and 410 
nucleosomes with two H3P38V tails are sufficient to prevent cryptic transcription either 411 
in natural, symmetric nucleosomes (31) or in our asymmetric nucleosomes (Figure 5, 412 
lane 16). Finally, the K36Q/P38V trans strains indicate that a single dimethylated K36 413 
residue is sufficient to prevent stress sensitivity (Figure 4F) and repress cryptic 414 
transcripts (Figure 5, lanes 17-18). Together, these data indicate that a single K36-415 
dimethylated H3 tail per nucleosome is sufficient to prevent cryptic transcription, and to 416 
promote stress resistance.  417 
Notably, the RPD3S complex appears to be particularly well-suited to carrying 418 
out its regulatory functions even on chromatin that is less than fully methylated at 419 
H3K36. In vitro experiments show that RPD3S is able to bind to nucleosomal templates 420 
containing asymmetric H3K36me3 modifications (29). Further, although RPD3S binds 421 
with higher affinity to dinucleosomes than monosomes, it binds with high affinity to 422 
templates with a dimethylated nucleosome adjacent to a fully unmethylated one. These 423 
data suggest that the methyl-K36/RPD3S system would be buffered against transient 424 
reductions in H3K36me2-3 density, for example during DNA repair or replication-425 
mediated loss of modified histones. Our data extend these observations to indicate that 426 
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the enzyme can function effectively in vivo even if it can only engage a single 427 
H3K36me2 or me3 per nucleosome.  428 
 429 
H3S10 mutants affect H3K9 acetylation in cis 430 
As another demonstration of the utility of the H3X/H3Y system, we carried out mass 431 
spectrometry analysis of a histone “crosstalk” pathway. Here, we take advantage of 432 
biotin-based purification to stringently separate a biotin-tagged H3X from an untagged 433 
H3Y (and vice versa) prior to mass spectrometry analysis. This method allows probing 434 
of histone crosstalk pathways in which one modification affects a second modification 435 
site. We show that H3S10A mutations decrease acetylation at the neighboring K9 436 
residue, but only on the molecule in cis. This is consistent with a recent in vitro study 437 
demonstrating that S10 phosphorylation stimulates H3 tail acetylation by Gcn5 only in 438 
cis (35). This example provides a clear example of how asymmetric nucleosomes can 439 
be used for detecting modification dependency relationships.  440 
 441 
Potential applications 442 
In addition to the two proof-of-concept analyses described above, we anticipate that the 443 
H3X/Y scaffold will provide a powerful tool for many additional studies, and we list a few 444 
potential applications here. First, we show here that the H3X/Y system assembles 445 
appropriately in vitro (Figure 3), providing a convenient method for generation of 446 
asymmetric nucleosomes for in vitro studies. This method should prove more 447 
generalizable than existing methods that rely on immunopurification (3, 7) or extensive 448 
chemical synthesis (38). Such asymmetric nucleosomes could be used to generate 449 
single-tailed nucleosomes for structural studies of tail-dependent nucleosome-binding 450 
proteins, significantly reducing the conformational heterogeneity resulting from the many 451 
flexible, unstructured histone tails. Nucleosomes carrying either asymmetric point 452 
mutations or asymmetric modified residues (generated using peptide ligation, for 453 
example – (39)) will facilitate detailed biochemical analyses of chromatin regulators, or 454 
selection of asymmetry-specific binding partners. Such studies can also be envisioned 455 
using asymmetric nucleosomes purified from living cells – thus occupying a wide range 456 
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of DNA sequences and carrying a multitude of covalent modifications – as affinity-457 
tagged X and Y halves of the heterodimer allow for efficient and rapid purification of 458 
chromatin composed of asymmetric nucleosomes (Figure 3 – Figure Supplement 1C). 459 
In addition to improving on extant methods to generate asymmetric nucleosomes 460 
in vitro, our system uniquely allows genetically-encoded assembly of asymmetric 461 
nucleosomes across the genome in living cells. We describe here one example of in 462 
vivo analysis of the gene regulatory consequences resulting from single vs. double H3 463 
mutations for H3K36Q, which can of course be extended to additional H3 mutations and 464 
to genome-wide or single-cell analyses. Although such studies are demonstrated here 465 
using the budding yeast system, the H3-H3 interface is generally highly conserved 466 
throughout evolution, and we expect that this system should function appropriately in 467 
other species – indeed, the biochemical reconstitution of asymmetric nucleosomes 468 
described in Figure 3 is carried out using human histone sequences. Although 469 
canonical histone genes are often encoded in many copies in large multi-gene genomic 470 
clusters and are therefore inconvenient for genetic studies, a Drosophila model has 471 
been developed in which the histone genes have been relocated to an artificial locus 472 
(40). Along with S. pombe, these models should enable analysis of H3K9/HP1 and 473 
H3K27/Polycomb repression systems in vivo. In addition, even in other model 474 
organisms we expect that low copy number H3 molecules such as H3.3 and CENP-A 475 
should prove amenable to analysis using the H3X/Y system. 476 
In any of these systems, the X/Y heterodimer will not just allow analysis of single 477 
vs. double mutations of the same residue, but will also enable cis and trans dissection 478 
of effects of combinatorial mutations (eg H3XK9R/H3YK14R vs. 479 
H3XK9RK14R/H3YWT). Fusing individual H3 molecules to labeling reagents such as 480 
BirA or Dam, or introduction of cysteine residues that can be used to create local nicks 481 
in the DNA, could potentially also be used to probe stereospecificity – facing from the 482 
promoter into a coding region, does a given nucleosome remodeler bind the left or the 483 
right H3 tail? – of nucleosome binding proteins. It is also possible to envision pulse-484 
chase methods for investigation of H3/H4 dimer mixing during replication and 485 
replication-independent nucleosome replacement. 486 
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Together, our data describe a versatile system for investigation of nucleosome 487 
symmetry, and demonstrate the utility of in vivo analysis of asymmetric nucleosomes as 488 
a mechanistic probe for histone modification function.  489 
 490 
 491 
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 502 
MATERIALS AND METHODS 503 
Plasmid Constructions and mutagenesis. C-terminal mutations of HHT2, one of the 504 
yeast genes encoding histone H3, were generated according to QuickChange Site-505 
Directed Mutagenesis protocol (Stratagene). Plasmids containing Myc- or Flag-tagged 506 
HHT2 were described previously (41). The insertion of the V5 or biotin acceptor tags at 507 
the 5’ end of HHT2 was generated by PCR. The DNA fragment containing the E. coli 508 
BirA gene (encoding biotin-protein ligase) (13) was cloned into a HIS3-marked 509 
integration vector downstream of the yeast GPD promoter and upstream of PGK 510 
terminator, and integrated into the his3 locus of strain PKY4171. 511 
 512 
Yeast strains and growth. Yeast growth and plasmid transformation of yeast cells 513 
were done according to standard yeast protocols. For plate assays, strains were grown 514 
overnight in 2 ml YPD medium at 30°C, five-fold dilutions (starting from OD600=0.6) were 515 
spotted on YPD-agar plates (with added compounds such as MMS when indicated), 516 
and incubated at indicated temperatures for 3-4 days. Analyses of osmotic stress 517 
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sensitivity (Figure 4, Figure 4 – Figure Supplement 1B) were performed in robotically-518 
manipulated cultures grown in 96-well plates – the growth rates in these experiments 519 
are internally consistent but distinct from growth measurements obtained in well-aerated 520 
liquid cultures (Figure 4 – Figure Supplement 1A). 521 
Low-copy plasmids containing mutated histone genes were introduced by LiOAc 522 
transformation, and then 5-FOA was used as a counterselecting agent to select against 523 
the URA3 plasmid containing the wild-type HHT1-HHF1 genes. All yeast strains (listed 524 
in Table S1) were derived from histone H3/H4 “shuffle” strain MSY421 from M. Smith 525 
and C.D. Allis (42), which has both chromosomal H3/H4-encoding loci deleted.  526 
 527 
Genetic screens for asymmetric mutants were carried out in: 528 
PKY4171  529 
MATa; (hht-hhf1); (hht2-hhf2); leu2-3,112; ura3-62; trp1; his3; bar1::hisG 530 
+ p(HHT1-HHF1, URA3, CEN) 531 
 532 
DMS crosslinking studies:  533 
PKY4171 derivatives with (HHT1-HHF1, URA3) plasmid replaced with: 534 
 535 
PKY4625 536 
+ P22 (Myc-H3Y = Myc-hht2(L109I, A110W, L130I), HHF2, LEU2) 537 
+ P67 (bio-H3X-126A = biotin-hht2(L126A, L130V), HHF2, TRP1) 538 
+ P72 (V5-H3X-126A = V5-hht2(L126A, L130V), HHF2, URA3) 539 
 540 
PKY4626 541 
+ P22 (Myc-H3Y = Myc-hht2(L109I, A110W, L130I), HHF2, LEU2) 542 
+ P71 (bio-H3X-130A = biotin-hht2(L126V, L130A), HHF2, TRP1) 543 
+ P73 (V5-H3X-130A = V5-hht2(L126V, L130A), HHF2, URA3) 544 
 545 
PKY4694 546 
+ P54 (biotin-H3Y = biotin-hht2(L109I, A110W, L130I), HHF2, LEU2) 547 
+ P72 (V5-126A = V5-hht2(L126A, L130V), HHF2, URA3) 548 
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+ P35 (Myc-H3Y = Myc-hht2(L109I, A110W, L130I), HHF2, TRP1) 549 
 550 
PKY4695 551 
+ P54 (biotin-H3Y = biotin-hht2(L109I, A110W, L130I), HHF2, LEU2) 552 
+ P73 (V5-130A = V5-hht2(L126V, L130A), HHF2, URA3) 553 
+ P35 (Myc-H3Y = Myc-hht2(L109I, A110W, L130I), HHF2, TRP1) 554 
 555 
Mass spectrometry samples were grown in derivatives of 556 
PKY4574 = PKY4171 with P65 (BirA::HIS3 integration plasmid) inserted.  557 
 558 
Directed evolution of improved H3X alleles. Plasmid P46 (hht2-(L126V, L130V), 559 
HHF2, TRP1) was used as the template to generate four PCR-generated libraries, each 560 
with randomized nucleotides at one of four H3 codons (109, 110, 126, 130). The full 561 
length PCR product was gel purified, self-ligated with T4 DNA ligase and transformed 562 
into competent E. coli Top10F’ cells. 1 ml LB was added after heat shock transformation 563 
and the cells recovered for 1.5 h at 37oC. 100 μl cells were plated to check the colony 564 
number, and the rest of the transformation was put into culture tube with another 2 ml 565 
LB and antibiotic to grow O/N before plasmid DNA miniprep (Zymo). The randomization 566 
of the desired codon in the four libraries of hht2 was confirmed by sequencing (Figure 1 567 
– Figure Supplement 1B). 568 
The four libraries were each transformed separately into yeast strain PKY4171, 569 
which carries the plasmid-borne wild-type H3 (URA3). 153 transformants were picked 570 
for each library and patched onto both SD-Trp-Ura and FOA plates at the same time. A 571 
subset of isolates was found inviable after incubation at 30oC for 10 days on FOA, 572 
indicating inability to grow the absence of wild type H3. These isolates were therefore 573 
chosen for the second step. For each library separately, cells from each FOA-sensitive 574 
isolate were pooled into 25 ml of SD media, grown to an A600 of ~0.5 and transformed 575 
with plasmid P44 (H3Y, H4, LEU2) and plated on SD-Trp-Leu. These transformants 576 
were then replica-plated onto FOA media. Plasmids from resulting FOA-resistant 577 
colonies were analyzed by colony PCR and sequencing. Candidate plasmids were 578 
retested by retransformation into PKY4171 with or without P44. The plasmids that 579 
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conferred robust growth on FOA media in the presence of P44 and no detectable 580 
growth in its absence encoded the hht2 variants termed 126A (carrying mutations 126A, 581 
130V), 130A (126V, 130A), 130T (126V, 130T), 130Q (126V, 130Q). 582 
 583 
Effects of the “pseudo-wild type” H3X/H3Y interface on yeast growth 584 
As asymmetric nucleosomes cannot be made on a wild-type H3 backbone, all 585 
experiments by necessity involve comparisons to pseudo-wild type yeast carrying the 586 
H3X/H3Y pair. Pseudo-wild type yeast are viable, but grow slowly relative to the 587 
parental strain in YPD at 30°C (Figure 4 – Figure Supplement 1A). In addition, they 588 
are temperature-sensitive and grow extremely poorly at 37°C. For this reason, 589 
temperature sensitivity in this system is assayed at 34°C (Figure 4D-F, Figure 4 – 590 
Figure Supplement 2). Importantly, the temperature-sensitivity phenotypes observed at 591 
this temperature occur in the same sets of mutants that grow poorly in high salt or in the 592 
presence of DNA-damaging agents (Figure 4). Thus, although the X/Y histone interface 593 
provides a sensitized assay for some phenotypes, it nevertheless represents a useful 594 
and internally-consistent platform for exploring important and physiologically-relevant 595 
aspects of gene regulation. 596 
 597 
Dimethyl suberimidate-crosslinked nucleosomes. 598 
100 ml cell cultures were grown in synthetic dextrose media to maintain selection for the 599 
three histone-encoding plasmids, with 250 nM biotin added to favor biotinylation of the 600 
tagged H3. Cells were harvested in early log phase (A600 ~0.25), pelleted and 601 
transferred to 1.5 ml O-ring microcentrifuge tubes (Fisher #02-707-353).  Cells were 602 
washed three times with 1 ml extraction (E) buffer (20 mM Na borate, pH 9.0, 0.35 M 603 
NaCl, 2 mM EDTA, plus 1 mM PMSF added freshly). Cells were resuspended in 900 l 604 
E buffer, and 0.5 ml glass beads (0.5 mm, Biospec) were added to each tube. Cell walls 605 
were mechanically broken with three one-minute pulses in a Biospec beadbeater, with 606 
five-minute incubations on ice between pulses. The tube bottoms were punctured with a 607 
flame-heated 26 gauge needle, placed into a 12 x 75 mm plastic tube and centrifuged 608 
for 2 min at 1500 rpm in a tabletop clinical centrifuge at 4°C. The liquid extracts were 609 
resuspended and transferred to 1.5 ml microfuge tubes. 1/10 volume freshly dissolved 610 
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11 mg/ml dimethyl suberimidate (Pierce) in E buffer was added, and samples were 611 
incubated with rotation at room temperature 90 minutes. For time point aliquots to be 612 
analyzed directly on gels, proteins were precipitated by addition of 1/10 volume 100% 613 
TCA. For material to be MNase-digested and immunoprecipitated, the crosslinker was 614 
quenched by addition of 50 mM Tris-Cl, pH 7.5 and further rotation for 15 min. 10 mM 615 
MgCl2 and 1 mM CaCl2 were added and tubes were equilibrated at 37°C for 5 minutes. 616 
20 l MNase (Worthington, 20 U/l in 10 mM Tris-Cl pH 7.4) were added, tubes were 617 
inverted five times and incubated at 37°C, 20 min. Digestion was stopped by moving 618 
tubes to 4°C, adding 40 l 0.25 M EDTA/EGTA and inversion to mix.  Material was 619 
centrifuged at 8000 x g for 1 min, 4°C, and pre-cleared by incubation with CL2B-620 
sepharose beads for 30 min 4°C and centrifugation at 8000 x g for 1 min, 4°C. The 621 
supernatant was the input for the pulldown assays. 30 l of a 50% slurry of streptavidin-622 
agarose beads was added to each tube, followed by rotation for 2 hours at 4°C. 623 
Samples were then centrifuged at 8000 x g for 1 min, 4°C and the beads were washed 624 
three times w/ 1 ml TE + 2 M NaCl + 0.2% Tween20, rotating at 4°C for 5 min each 625 
time. After the last wash all supernatant was removed and beads were resuspended in 626 
protein gel sample buffer. Proteins were separated on 17% SDS-PAGE gels and 627 
analyzed by immunoblotting; the 31kD H3-H3 crosslinked species was quantified on a 628 
BioRad Chemidoc system. 629 
 630 
Expression and purification of recombinant histones 631 
Yeast heterodimer ‘X’ (L126A, L130V) and ‘Y’ mutations (L109I, A110W, L131I) were 632 
introduced into codon-optimized human histone H3 sequences lacking cysteines. This 633 
yielded human heterodimer ‘X’ with the following point mutations: C96S, C110A, L126A, 634 
and I130V; and human heterodimer ‘Y’: C96S, L109I, C110W (human histone H3 635 
already has I131).  636 
All wild-type and mutant human histone H3 proteins were purified according to 637 
the rapid purification protocol previously described (43), with slight modifications. 638 
Specifically, codon optimised histone H3 (supplied by Entelechon – now Eurofins) was 639 
expressed from a pETM13 vector, transformed into the E. coli strain Rosetta (DE3) 640 
pLysS (Novagen). Bacteria were grown in LB medium (with 50 g ml-1 kanamycin and 641 
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25 g ml-1 chloramphenicol) at 37 °C. Protein expression was induced with 0.25 mM 642 
IPTG (OD600 = 0.6) and cells were harvested after 4 h by centrifugation. Cell pellets 643 
were resuspended in cold lysis buffer (7 M urea, 20 mM sodium acetate (pH 5.2), 200 644 
mM NaCl, 1 mM EDTA and 5 mM -mercaptoethanol) and cells lysed by sonication. 645 
The lysate was clarified by centrifugation at 75,600g for 20 minutes and the supernatant 646 
filtered using a 0.45 m syringe filter (HPF Millex, Millipore). The sample was injected 647 
onto connected HiTrap Q HP (5 ml) and HiTrap SP HP (5 ml) columns (GE Healthcare) 648 
pre-equilibrated in lysis buffer. Columns were washed with lysis buffer before removing 649 
the HiTrap Q column. Histone H3 was eluted from the HiTrap SP column with a 12 CV 650 
gradient into 60% elution buffer (lysis buffer with 1 M NaCl). Fractions containing 651 
histone H3 were pooled, concentrated and dialysed into 1 mM DTT. Finally, the 652 
histones were aliquoted and lyophilised for storage. 653 
Human histone H4 (kindly provided by T.Bartke) and the H2A/H2B dimer were 654 
purified as previously described (44). 655 
 656 
Nucleosome reconstitution 657 
Purified histones were used to attempt the assembly of histone octamers, as previously 658 
described (44). Briefly, histones dissolved in unfolding buffer (20 mM Tris (pH 7.5), 6 M 659 
guanidine hydrochloride, and 20 mM DTT) were mixed in equimolar ratios and diluted to 660 
a final concentration of 1 mg ml-1. The histones were extensively dialysed against 661 
refolding buffer (10 mM Tris (pH 7.5), 2 M NaCl, 1 mM EDTA and 5 mM -662 
mercaptoethanol) before being concentrated and purified by size exclusion 663 
chromatography (Superdex 200 Increase 3.2/300 column; GE Healthcare). Pooled 664 
fractions were concentrated and combined with 167 bp Widom DNA at an equilmolar 665 
concentration, with the aim of reconstituting nucleosomes by salt deposition (45) using 666 
buffers containing 20 mM Tris (pH 7.5), 5 mM  -mercaptoethanol, 1 mM EDTA, and the 667 
following NaCl concentrations: 2 M, 850 mM, 650 mM and 150 mM. Following dialysis, 668 
the samples were centrifuged at 20,000g to remove any precipitate before nucleosome 669 
assembly was assessed by native PAGE (5 % polyacrylamide, 3% glycerol, 0.5 X TAE; 670 
100 V for ~1.5 h at 4 °C). 671 
 672 
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Mass spectrometric analysis of biotinylated H3 from asymmetric nucleosomes.  673 
1000 ml cultures were grown in YPD + 250 nM biotin at 30°C to mid-late log phase 674 
(A600 = 0.4-0.7). Then, sodium azide and phenylmethylsulfonyl fluoride were added to 675 
the medium at final concentrations of 0.1% and 5 mM, respectively.  Cells were pelleted 676 
and collected into two to four O-ring tubes as above, and washed twice with buffer TG 677 
(0.1 M Tris-Cl, pH 8.0, 20% glycerol) + protease/deacetylase/phosphatase inhibitors: 1 678 
mM PMSF, 0.5 g/ml leupeptin, 0.7 g/ml pepstatin, 1.0 g/ml E64, 1.0 g/ml aprotinin, 679 
1 mM benzamidine) + 20 mM Na butyrate, 2 mM nicotinamide, 1 mM EDTA, 1 mM 680 
Na3VO4. Tubes were frozen in liquid nitrogen and stored at -80C. All subsequent steps 681 
were on ice or at 4°C. 682 
Each tube of frozen cells was resuspended in 900 l TG buffer with the inhibitors 683 
described above, plus 0.5 ml glass beads (0.5 mm, Biospec). Cell walls were broken by 684 
bead beating, and beads were removed as described above. Liquid extracts were 685 
transferred to 1.5 ml eppendorf tubes, and centrifuged 7K rpm, 5 min (4.5K x g). The 686 
cytosolic supernatant was removed and the pellet was resuspended in 1 ml Buffer L (50 687 
mM Hepes-KOH pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium 688 
deoxycholate) + inhibitors as described above. Chromatin was sheared in a Bioruptor 689 
(Diagenode) for 30 min (2 x 15 minute rounds of 30’’ on/30” off on “High” power; 690 
samples were chilled on ice 10 minutes between rounds). Extracts were transferred to 691 
microfuge tubes, centrifuged at 6K rpm (= 3.3K x g) for 10 min. The supernatant was the 692 
input for the pulldown assays. 30 l of a 50% slurry streptavidin-agarose beads was 693 
added to each tube, followed by rotation for 2 hours at 4°C. (Beads were pre-694 
equilibrated and blocked in Buffer L + inhibitors + 10 g insulin per sample.) Samples 695 
were centrifuged at 8000 x g for 1 min, and the beads were washed three times with 1 696 
ml TE + 2 M NaCl + 2 M urea, rotating at 4°C for 5 min each time. To remove salt for 697 
mass spectrometry, beads were washed three times with water, snap-frozen and stored 698 
at -80°C. 699 
 700 
On-bead histone propionylation and tryptic digestion. Biotin-tagged histone H3 701 
bound to streptavidin beads were washed twice with 300µl of 100mM ammonium 702 
bicarbonate. For in vitro propionylation of histone H3, 300µl of a 3:1 703 
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isopropanol:propionic anhydride mixture was added followed by ammonium hydroxide 704 
to adjust pH to ~8. The beads were incubated at 51oC for 20 min. Beads were then 705 
collected by centrifugation at 1000 rpm for 60 s and washed with ammonium 706 
bicarbonate before a second round of propionic anhydride treatment. The washed 707 
beads were resuspended in 50mM ammonium bicarbonate and incubated with 2µg of 708 
Promega sequencing grade trypsin overnight at 370C. The digest was then derivatized 709 
with propionic anhydride using the same protocol as described above. Histone peptides 710 
were extracted from the beads with 200 l of 50% acetonitrile in water. Peptides were 711 
completely dried in a SpeedVac concentrator and then resuspended in 0.1% 712 
triflouroacetic acid for MS analysis. 713 
 714 
Liquid chromatography single reaction monitoring mass spectrometry (LC-SRM-715 
MS). Histone peptides were injected in triplicate onto a TSQ Quantum mass 716 
spectrometer (ThermoFisher Scientific) directly linked to a Dionex nano-LC system. 717 
Peptides were first loaded onto a trapping column (3 cm × 150 µm) and then separated 718 
with an analytical capillary column (10 cm × 75 µm). Both were packed with ProntoSIL 719 
C18-AQ, 3µm, 200Å resin (New Objective). The chromatography gradient was achieved 720 
by increasing percentage of buffer B from 0 to 35% at a flow rate of 0.30 µl/min over 45 721 
min. Solvent A: 0.1% formic acid in water, and B: 0.1% formic acid in 95% acetonitrile. 722 
The peptides were then introduced into the MS by electrospray from an emitter with 10 723 
µm tip (New Objective) as they were eluted from analytical column. The instrument 724 
settings were as follows: collision gas pressure of 1.5 mTorr; Q1 peak width of 0.7 725 
(FWHM); cycle time of 3 s; skimmer offset of 10 V; electrospray voltage of 2.5 kV. 726 
Targeted analysis of unmodified and various modified histone peptides were performed. 727 
Raw MS files were imported and analyzed in Skyline with Savitzky-Golay 728 
smoothing (46). All Skyline peak area assignments were manually confirmed. Total 729 
peak areas normalized to a non-modified H3 peptide were used to plot bar graphs 730 
representing relative proportions of distinct histone modifications. The relative 731 
abundances were determined from the mean of three technical replicates with error 732 
bars showing standard deviation. 733 
 734 
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Affinity purification of salt-washed chromatin  735 
These preparations were performed as described above for the mass spectrometry 736 
samples with the following modifications. 100 ml cultures were grown to late log phase 737 
(OD600 = 1 to 3) in YPD + 250 nM biotin and cells were immediately subjected to bead 738 
beating. After removal of the cytosolic supernatant, pellets were washed three times 739 
with 1.0 ml Wash Buffer (10 mM Tris-Cl, pH 8.0, 1 mM EDTA, 0.1 % Triton X-100, 0.5 M 740 
NaCl + protease inhibitors/PTM inhibitors as described above), spinning at 4.5K x g for 741 
5 minutes at each step. The washed chromatin resuspended in 1.0 ml Wash Buffer and 742 
sheared in a Bioruptor as described above. The soluble chromatin was fractionated 743 
using streptavidin-agarose as described above, except that the washes were performed 744 
three times with 1.0 ml Wash Buffer. Bound material from each preparation was 745 
resuspended in 50 l SDS-PAGE gel sample buffer.  746 
 747 
Northern Blot Analysis 748 
Cells were grown in YPD medium to mid-exponential phase (OD600 = 0.4 to 0.7), and 749 
collected by filtration.  RNA was prepared by a hot phenol method (47). Northern blot 750 
analysis was performed as described previously (48) with following modifications:  751 
STE11 and FLO8 PCR fragments (49) were used as probes that were labeled with 752 
alkaline phosphatase using Amersham AlkPhos Direct Labeling and Detection Systems 753 
(GE healthcare). Blots were exposed to HyBlot CL Autoradiography Film (Denville 754 
Scientific).  Signal intensity was quantified by using ImageJ. 755 
 756 
Primers for Northern probe (49): 757 
o-STE11-11: GAA GGA GTT ACA TCA TGA GAA CAT TGT TAC  758 
o-STE11-12: GTG TGC ATC CAG CCA TGG ATG CTG CAG CAA  759 
o-FLO8-13: GAC GCT CAG AAG CAA AGA AGT TCT AAG GTA  760 
o-FLO8-14: CTC AAC ACG TGA CTT CAG CCT TCC CAA TTA 761 
 762 
FIGURE LEGENDS 763 
Figure 1: Design and testing of asymmetric nucleosomes. 764 
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A) Schematic of asymmetric histone H3 design. Left: Wild-type H3/H4 tetramers are 765 
symmetrical, with H3-H3 interactions serving as the dimerization interface. The H3 N-766 
terminus, site of many modifiable residues, is indicated protruding from the globular 767 
domain. Right: Obligate heterodimer H3s are comprised of distinct “X” and “Y” 768 
interaction partners which are altered to prevent either H3 from homodimerizing. 769 
B) Computational models of the designed histone H3 heterodimer. (1) The four-helix 770 
bundle comprising the H3-H3 C-terminal dimerization interface (pdb 1kx3). Leucine and 771 
alanine residues at the hydrophobic interface are indicated. (2) The designed 772 
asymmetric mutations pack efficiently as a heterodimer, with partners colored in green 773 
(H3Y) and yellow (H3X). Indicated residues at the H3-H3 interface were engineered to 774 
form a bump-hole interface to increase interaction affinity. (3-4) Altered H3s are 775 
designed not to homodimerize due to van der Waals clashes (3) or voids (4) in the 776 
hydrophobic core. 777 
C-D) Genetic analysis of heterodimeric H3X/H3Y pairs. 778 
C) H3Y alone cannot support growth. Images show growth of yeast carrying wild-type 779 
H3 on a URA3-marked plasmid as well as either empty plasmid, wild-type H3, H3Y 780 
alone, or both H3X and H3Y. Three independent transformants for each strain were 781 
grown on 5-FOA to select against the URA3 shuffle plasmid. 782 
D) H3X alone cannot support growth. Left panels: growth of three independent 783 
transformants of various H3X strains (evolved second-generation mutations indicated at 784 
left) in the absence of H3Y. Bottom: positive control with a TRP1-marked wild-type 785 
histone plasmid. Right panels: growth of indicated H3X strains in the presence of H3Y. 786 
Synthetic complete (SC) plates were grown 3 days, FOA plates 9 days. No growth on 787 
FOA was observed for any of the four evolved H3X alleles in the absence of H3Y, even 788 
after extended incubation. 789 
E) Sequences of final H3X-H3Y molecules. All four H3X variants have been validated 790 
genetically, while two variants – 126A/130V and 126V/130A – have been validated 791 
biochemically (see Figure 2 and not shown). 126A is used for all functional analyses. 792 
 793 
Figure 2: Biochemical analysis of asymmetric nucleosome formation in vivo. 794 
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A) Schematic for in vivo biochemical analysis of H3X dimerization. Yeast strains 795 
expressed biotin-tagged H3X along with tagged H3X and H3Y, as indicated. 796 
B) Immunoblot analysis of biotin-H3X partners. For each of the indicated antibodies 797 
(Myc or V5, the same blot was probed sequentially), the left two lanes show total DMS-798 
crosslinked, MNase-digested chromatin (Input), and right lanes show streptavidin-799 
precipitated biotinylated-H3 (Bound). Arrow indicates the expected size (31 kD) of 800 
crosslinked H3-H3 dimer species – note that biotin-H3 molecules crosslinked to H4 801 
would not be recognized by the anti-epitope antibodies used for Western blot analysis.  802 
Asterisk indicates monomeric H3 molecules – presence of V5-tagged H3X (left panel) at 803 
this position in the bound fraction reflects bead contamination by uncrosslinked H3 804 
molecules. Full gel, including unbound material and DMS control, is shown in Figure 2 805 
– Figure Supplement 2. 806 
C) Quantitation of the amounts of the crosslinked 31kD H3-H3 dimers precipitated with 807 
streptavidin-agarose for second-generation H3X variant 126A. The mean and standard 808 
deviation for 3 independent replicate experiments are shown. 809 
D-F) As in (A-C), but for biotin-tagged H3Y. As above, the homodimer signal (Myc, right 810 
panel) at 31kD in the bound material was almost undetectable, while V5-tagged 811 
H3X/H3Y heterodimers were readily detected. The mean and standard deviation for 3 812 
independent replicate experiments are quantitated in panel (F). 813 
 814 
Figure 3: Human histone H3 mutants ‘X’ and ‘Y’ form obligate heterodimers in 815 
vitro. 816 
A) Size exclusion (Superdex 200 Increase 3.2/300) gel filtration profiles showing the 817 
purification of octamer refolding reactions containing wild-type and heterodimer ‘X’ and 818 
‘Y’ histone H3. Octamer refolding in the presence of both ‘X’ and ‘Y’ H3 yields histone 819 
octamers with a characteristic elution profile, similar to refolding reactions containing 820 
wild-type H3, while reconstitutions with only H3X or only H3Y form aggregates. 821 
B) Native PAGE analysis of nucleosome reconstitution experiments with purified 822 
histones from (A). H3X/Y octamer reconstitutions readily form nucleosomes when 823 
assembled onto DNA, while the aggregates formed in octamer refolding reactions 824 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
containing either ‘X’ or ‘Y’ alone do not form histone octamers and therefore cannot 825 
form nucleosomes in vitro. 826 
 827 
Figure 4: Genetic epistasis between the H3 tails. 828 
(A-B) We constructed 12 sets of point mutations in histone H3, with each mutant cycle 829 
including H3Xmut/H3Ywt, H3Xwt/H3Ymut, and H3Xmut/H3Ymut – for each mutant 830 
trio, X/Y/double mutations are ordered from left to right, as indicated with 831 
green/yellow/blue boxes in Panel (B). For all 12 trios, as well as the matched “pseudo-832 
wt” (labeled as pWT) carrying H3Xwt/H3Ywt (leftmost bar and dashed line), we 833 
measured doubling times in at least 6 replicate cultures in low (A) and high (B) KCl. 834 
Boxes emphasize H3K14R and H3K36Q trios, as detailed in text. Note that growth rates 835 
here were measured robotically in a 96-well format, so doubling times are slower than 836 
those typically measured in well-aerated cultures (Figure 4 – Figure Supplement 1A). 837 
(C) Effects of H3K36Q mutants on DNA damage sensitivity. Serial dilutions of the 838 
indicated strains were plated on YPD, YPD + 10 ng/ml phleomycin or YPD + 0.025% 839 
MMS, as indicated.  pWT XY (PKY4704), K36Q mXY (PKY4829), K36Q XmY 840 
(PKY4831), K36Q mXmY (PKY4834), K36Q_X/P38V_Y (PKY5138), and 841 
P38V_X/K36Q_Y (PKY5140). 842 
D-F) Serial dilution growth assay for the indicated strains incubated at 30 C or 34 C, as 843 
indicated. Note that yeast carrying pseudo-wild type H3X/H3Y nucleosomes grow poorly 844 
at 37C, so we assayed temperature sensitivity at 34 C. Mutant set in (D) shows 845 
temperature-sensitivity is specific to symmetric H3K36Q mutant. Mutant set in (E) 846 
shows that complete loss of H3K36me3 in the symmetric H3P38V mutant (where 847 
H3K36me3 is replaced with H3K36me2) is compatible with rapid growth at high 848 
temperatures. Mutant set in (F) shows that a single dimethylated K36 residue per 849 
nucleosome is compatible with rapid growth at high temperatures.  850 
 851 
Strains analyzed were: pWT XY (PKY4704), R2K mXY (PKY4749), R2K XmY 852 
(PKY4751), R2K mXmY (PKY4753), K9Q mXY (PKY4714), K9Q XmY (PKY4715), K9Q 853 
mXmY (PKY4706), K9R mXY (PKY4773), K9R XmY (PKY4775), K9R mXmY 854 
(PKY4777), S10A mXY (PKY4716), S10A XmY (PKY4717), S10A mXmY (PKY4707), 855 
K14Q mXY (PKY4789), K14Q XmY (PKY4791), K14Q mXmY (PKY4793), K14R mXY 856 
(PKY4781), K14R XmY (PKY4783), K14R mXmY (PKY4786), K18Q mXY (PKY4805), 857 
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K18Q XmY (PKY4807), K18Q mXmY (PKY4809), K18R mXY (PKY4797), K18R XmY 858 
(PKY4799), K18R mXmY (PKY4801), K27Q mXY (PKY4822), K27Q XmY (PKY4823), 859 
K27Q mXmY (PKY4825), K27R mXY (PKY4813), K27R XmY (PKY4815), K27R mXmY 860 
(PKY4817), K36Q mXY (PKY4829), K36Q XmY (PKY4831), K36Q mXmY (PKY4834), 861 
K37Q mXY (PKY4837), K37Q XmY (PKY4839), K37Q mXmY (PKY4841), P38V mXY 862 
(PKY5033), P38V XmY (PKY5035), P38V mXmY (PKY5037), K36Q mX/P38V mY 863 
(PKY5138), and P38V mX/K36Q mY (PKY5140). 864 
 865 
pWT XY, pseudo WT; mXY, mutation on X; XmY, mutation on Y; and mXmY, mutation 866 
on both X and Y. 867 
 868 
Figure 5: Double H3K36Q mutants fail to repress cryptic promoters. 869 
A) Northern blot for STE11 for RNA isolated from the indicated strains, with 25S 870 
Northern shown as a loading control. Top band, which migrates at 2.2 kb, represents 871 
the full-length STE11 transcript, while the two lower molecular-weight bands correspond 872 
to previously-characterized sense transcripts initiating within the STE11 coding region 873 
from cryptic promoters (32). 874 
B) Quantitation of cryptic transcript levels for STE11 in the various strains indicated 875 
(n=3). Levels of cryptic transcripts were normalized to full-length. Average and std. dev. 876 
of triplicate measures of these normalized values are graphed on the y-axes. 877 
 878 
Strains analyzed were: WT wt-c (PKY4701), K36Q wt-c (PKY4827), eaf3Δ WT wt-c 879 
(PKY5077), eaf3Δ K36Q wt-c (PKY5079), P38V wt-c (PKY5031), pWT XY (PKY4704), 880 
K36Q mXY (PKY4829), K36Q XmY (PKY4831), K36Q mXmY (PKY4834), eaf3 pWT 881 
XY (PKY5081), eaf3 K36Q mXY (PKY5083), eaf3 K36Q XmY (PKY5086) and eaf3 882 
K36Q mXmY (PKY5087), P38V mXY (PKY5033), P38V XmY (PKY5035), P38V mXmY 883 
(PKY5037), K36Q mX/P38V mY (PKY5138), and P38V mX/K36Q mY (PKY5140). 884 
 885 
pWT_XY, pseudo wild-type; mXY, mutation on X; XmY, mutation on Y; and mXmY, 886 
mutation on both X and Y. 887 
 888 
Figure 6: H3S10A affects histone crosstalk in cis.  889 
A) Mass spectrometric analysis of H3X/H3Y heterodimers expressing one biotin-labeled 890 
subunit, with a S10A point mutation either located on the same H3 molecule (in cis), or 891 
in trans. Left: Schematic of asymmetric nucleosomes. Right: Robust avidin-affinity 892 
purification of biotin-labeled H3 molecules. Mass spec quantitation of peptides 893 
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(described on top of the graphs) from the strains with genotypes indicated on the x-894 
axes. For each peptide, raw peak area scores were normalized by dividing by the peak 895 
areas of an internal control, the unmodified H3 peptide containing K42. Average and 896 
std. dev. of triplicate measures of these normalized values are graphed on the y-axes. 897 
As expected, S10A-containing peptides were only detected when present in cis on the 898 
biotin-labeled histone, but not when expressed in trans on the heterodimeric partner. 899 
B) H3K9 acetylation levels are diminished in cis in H3S10A mutants. Data are shown for 900 
mass spec analysis of the indicated mutant strains. Left two bars show data for wild-901 
type and double H3S10A mutants on the background of a wild-type H3-H3 interface. 902 
Right four panels show H3K9Ac levels on an avidin-purified biotin-tagged H3 molecule, 903 
showing data for H3X acetylation in the context of the pseudo-wild type H3X/Y 904 
background, H3X acetylation on the same (cis) or opposite tail from an H3S10A 905 
mutation, and H3X acetylation in a double H3XS10A/H3YS10A mutant. 906 
C) Western blots confirming effects of symmetric S10A on K9 acetylation both on the 907 
WT H3-H3 background, and on the X-Y background, as indicated. For the right panel, 908 
the epitope tag present on H3X allows separate probing of the H3X and H3Y molecules. 909 
Total protein on blots was visualized by Ponceau S staining. Note that although the 910 
S10A mutation in principle might affect anti-H3K9ac antibody (Abcam ab10812) binding, 911 
these results are highly concordant with the mass spectrometry measurements in panel 912 
(B), where the ability to detect lysine acetylation (based on peptide mass) is unaffected 913 
by the difference between S10 and S10A. 914 
D-F) Quantitation of blots from panel (C). K9Ac signals were normalized to total protein 915 
detected by Ponceau S. 916 
Strains analyzed were: WT wt-C (PKY4610), S10A wt-C (PKY5003), pWT-XY 917 
(PKY4983), S10A-XY-cis (PKY5005), S10A-XY trans (PKY4986) and S10A-XY double 918 
(PKY5042). 919 
 920 
 921 
SUPPLEMENTAL MATERIALS 922 
Supplementary File 1 923 
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Figure 1-figure supplement 1 924 
Figure 2-figure supplements 1-2 925 
Figure 3-figure supplement 1 926 
Figure 4-figure supplements 1-3 927 
Figure 5-figure supplement 1 928 
 929 
 930 
SUPPLEMENTARY FILES 931 
Supplementary Table 1. Yeast strain list. 932 
 933 
 934 
SUPPLEMENTAL FIGURE LEGENDS 935 
Figure 1-figure supplement 1 936 
Optimization of the H3X/H3Y design. 937 
A) Genetic analysis of the original H3X design. The top four panels are identical to 938 
Figure 1C, showing growth of H3X/H3Y-bearing yeast strains but no growth of H3Y-939 
bearing strains, and are duplicated here for comparison to H3X growth phenotypes. 940 
Bottom two panels: Yeast bearing a wild type histone-URA3 shuffle plasmid were 941 
transfected with the indicated plasmids carrying a wild-type H4 gene and the original 942 
H3X (126V, 130V) gene. Three independent isolates of each strain were patched onto 943 
5-FOA media to select for loss of the wild type histone-URA3 plasmid. Strains were 944 
grown for the indicated number of days and photographed. The growth of papillae in the 945 
absence of H3Y upon extended incubation led us to optimize H3X by randomization of 946 
four key residues, as shown below.  947 
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B) Sequencing traces for the four “H3X*” libraries, each with one randomly mutagenized 948 
codon as indicated. Although the base utilization in the synthetic oligonucleotides is not 949 
completely equal, all four bases are readily detected at each position. 950 
C) Schematic of the screening strategy. Transformants carrying the H3X* library alleles 951 
were plated on SC-Trp and replicated onto FOA plates. Strains that couldn’t survive on 952 
FOA with H3* alone were transformed with an H3Y-expressing plasmid, and then were 953 
tested on FOA media to assess the viability of the H3X*-H3Y combinations (as shown in 954 
Figure 1C). As an additional criterion, we tested whether the two plasmids expressing 955 
the new H3X/H3Y heterodimers were stable when cells were cultured in rich media in 956 
the absence of selection for either plasmid. Repeated rounds of streaking on rich (YPD) 957 
plates or culturing in YPD media yielded colonies that all maintained a Trp+Leu+ 958 
phenotype, indicating that neither plasmid could be lost. Furthermore, resequencing of 959 
plasmids isolated after growth on YPD detected no reversion of the engineered H3X or 960 
H3Y in 96 independent isolates. Together, the genetic data strongly suggest that the 961 
H3X/H3Y combinations are obligate heterodimers, and that neither H3X nor H3Y can 962 
homodimerize at sufficient levels to support viability. 963 
 964 
Figure 2-figure supplement 1 965 
DMS crosslinking efficiency. 966 
A) Schematic for in vivo biochemical analysis of H3 dimerization. Yeast strains used 967 
were PKY4616 (top, biotin-tagged wild-type H3 + V5-tagged wild-type H3), PKY4625 968 
(middle, biotin-H3X + V5-H3X + Myc-H3Y), and PKY4694 (bottom, biotin-H3Y + V5-H3X 969 
+ Myc-H3Y). 970 
B) Immunoblot analysis of strains shown in (A).  Whole cell extracts after 0 or 60 971 
minutes of DMS crosslinking (- DMS or + DMS, respectively) were separated by 17% 972 
SDS-PAGE, transferred to a membrane, and probed with anti-V5 antibody. 973 
C) Quantitation of the dimer/monomer ratio of H3 proteins after DMS crosslinking. The 974 
mean and standard deviation for 3 independent replicate experiments are graphed. 975 
 976 
Figure 2-figure supplement 2 977 
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Western blot analysis of asymmetric nucleosome formation in vivo. 978 
A) Immunoblot analysis of Biotin-H3X126A strain. Lanes 3-4 and 7-8 from these gels are 979 
reproduced in Figures 2B, E. Lanes 1-2: whole cell extracts after 0 or 60 minutes of 980 
DMS crosslinking. Lanes 3-8: DMS-crosslinked, MNase-digested chromatin from the 981 
indicated strains was precipitated with streptavidin-agarose to capture biotinylated (Bio) 982 
H3. I=Input, U= Unbound: 0.75% and 1.5% of total shown in adjacent lanes; B = Bound: 983 
10 and 20% of total shown. Proteins were separated by 17% SDS-PAGE, transferred to 984 
a membrane, and probed sequentially with the indicated primary antibodies. Arrow 985 
indicates the expected size of crosslinked H3-H3 dimer species, while asterisk indicates 986 
monomeric H3 molecules – presence of V5-tagged H3X (left panel) at this position in 987 
the bound fraction reflects bead contamination by uncrosslinked H3 molecules. 988 
B) As in A, for biotin-H3Y. 989 
 990 
Figure 3-figure supplement 1 991 
Generation of asymmetric X/Y nucleosomes for in vitro studies. 992 
A) Purified recombinant histones. 993 
B) Replicate size exclusion (Superdex 200 Increase 3.2/300) gel filtration profiles 994 
showing the purification of octamer refolding reactions containing wild-type and 995 
heterodimer ‘X’ and ‘Y’ histone H3. As in Figure 3A, with additional replicate shown. 996 
C) Coomassie Blue G staining of affinity-purified chromatin composed of asymmetric 997 
nucleosomes. Chromatin was washed with buffer containing 0.1% Triton X100 and 0.5 998 
M NaCl and purified by binding to streptavidin-agarose in the same buffer. Strains 999 
expressed the indicated combination of X-Y asymmetric H3s. 10 l (lanes 1, 4, 6), 5 l 1000 
(lanes 2, 5, 7) or 2.5 l (lane 3) of the bound material was analyzed on a 15% SDS-1001 
PAGE gel.  1002 
 1003 
Figure 4-figure supplement 1 1004 
Significant growth defects for the H3K36Q double mutant, relative to either single 1005 
mutant. 1006 
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A) The X/Y interface confers slow growth relative to the wild-type H3 interface. Growth 1007 
rates of the indicated strains are shown for growth in liquid YPD media at 30C in well-1008 
aerated flasks. Strains analyzed were BY4741 (wild-type strain with no histone gene 1009 
deletions), “wt H3” = PKY4701, the histone shuffle strain with a plasmid expressing wild-1010 
type H3/H4, wt X-Y#1 and #2 = PKY4704 and 4705, two different PKY4701 1011 
derivatives coexpressing the heterodimeric X-Y H3 derivatives. 1012 
B) Dot plots show all growth rates in 0.8M KCl for all individual replicate time courses for 1013 
the indicated H3K36Q mutants. These measurements were performed in 96-well plates. 1014 
 1015 
Figure 4-figure supplement 2 1016 
Temperature sensitivity of various histone mutant strains. 1017 
For all panels, serial dilutions of the indicated strains were plated at 30 C, 34 C, or 37 C, 1018 
as indicated. 1019 
A) Data for WT wt-c (PKY4701), K36Q wt-c (PKY4827), P38V wt-c (PKY5031), eaf3Δ 1020 
WT wt-c (PKY5077) and eaf3Δ K36Q wt-c (PKY5079). 1021 
B) Data for WT wt-c (PKY4701), K14R wt-c (PKY4779), K14Q wt-c (PKY4787) and 1022 
K56R wt-c (PKY4843). 1023 
C) Data for pWT XY (PKY4704), eaf3 pWT XY (PKY5081), eaf3 K36Q mXY 1024 
(PKY5083), eaf3 K36Q XmY (PKY5086) and eaf3 K36Q mXmY (PKY5087). 1025 
D) Data for pWT XY (PKY4704), K14R mXY (PKY4781), K14R XmY (PKY4783) and 1026 
K14R mXmY (PKY4786). 1027 
E) Data for pWT XY (PKY4704), K14Q mXY (PKY4789), K14Q XmY (PKY4791) and 1028 
K14Q mXmY (PKY4793) 1029 
pWT_XY, pseudo WT; mXY, mutation on X; XmY, mutation on Y; and mXmY, mutation 1030 
on both X and Y. 1031 
 1032 
Figure 4-figure supplement 3 1033 
H3P38V mutations block trimethylation but not dimethylation of H3K36. 1034 
Whole cell extracts of the indicated strains were separated by 15% SDS-PAGE and 1035 
transferred to a membrane. The same blot was probed sequentially with the following 1036 
antibodies: anti-H3K36me3 (Active Motif MABI0333), anti-H3K36me2 (Abcam ab9049) 1037 
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and anti-H3K79me3 (GeneTexRM157).  Strains analyzed were: pWT XY (PKY4704), 1038 
K36Q mXmY (PKY4834), P38V_X/K36Q_Y (PKY5140), P38V mXmY (PKY5037). 1039 
 1040 
Figure 5-figure supplement 1 1041 
Effects of H3K36Q mutants on cryptic transcription. 1042 
As in Figure 5, with FLO8 used as a probe for Northern blots in place of STE11. 1043 
 1044 
REFERENCES 1045 
 1046 
 1047 
1. A. L. Hughes, O. J. Rando, Mechanisms Underlying Nucleosome Positioning in vivo. Annual 1048 
review of biophysics,  (2014). 1049 
2. R. D. Kornberg, Y. Lorch, Twenty-five years of the nucleosome, fundamental particle of the 1050 
eukaryote chromosome. Cell 98, 285-294 (1999). 1051 
3. P. Voigt et al., Asymmetrically modified nucleosomes. Cell 151, 181-193 (2012). 1052 
4. E. Shema et al., Single-molecule decoding of combinatorially modified nucleosomes. Science 1053 
(New York, N.Y 352, 717-721 (2016). 1054 
5. H. S. Rhee, A. R. Bataille, L. Zhang, B. F. Pugh, Subnucleosomal Structures and Nucleosome 1055 
Asymmetry across a Genome. Cell 159, 1377-1388 (2014). 1056 
6. S. Ramachandran, G. E. Zentner, S. Henikoff, Asymmetric nucleosomes flank promoters in the 1057 
budding yeast genome. Genome research 25, 381-390 (2015). 1058 
7. S. Li, M. A. Shogren-Knaak, Cross-talk between histone H3 tails produces cooperative 1059 
nucleosome acetylation. Proceedings of the National Academy of Sciences of the United States 1060 
of America 105, 18243-18248 (2008). 1061 
8. S. Li, M. A. Shogren-Knaak, The Gcn5 bromodomain of the SAGA complex facilitates cooperative 1062 
and cross-tail acetylation of nucleosomes. The Journal of biological chemistry 284, 9411-9417 1063 
(2009). 1064 
9. K. Luger, A. W. Mader, R. K. Richmond, D. F. Sargent, T. J. Richmond, Crystal structure of the 1065 
nucleosome core particle at 2.8 A resolution. Nature 389, 251-260 (1997). 1066 
10. S. L. Mayo, B. D. Olafson, W. A. Goddard, DREIDING: a generic force field for molecular 1067 
simulations. J Phys Chem 94, 8897-8909 (1990). 1068 
11. D. N. Bolon, R. A. Grant, T. A. Baker, R. T. Sauer, Specificity versus stability in computational 1069 
protein design. Proceedings of the National Academy of Sciences of the United States of America 1070 
102, 12724-12729 (2005). 1071 
12. J. Dai et al., Probing nucleosome function: a highly versatile library of synthetic histone H3 and 1072 
H4 mutants. Cell 134, 1066-1078 (2008). 1073 
13. D. Beckett, E. Kovaleva, P. J. Schatz, A minimal peptide substrate in biotin holoenzyme 1074 
synthetase-catalyzed biotinylation. Protein Sci 8, 921-929 (1999). 1075 
14. R. D. Kornberg, J. O. Thomas, Chromatin structure; oligomers of the histones. Science (New York, 1076 
N.Y 184, 865-868 (1974). 1077 
15. J. O. Thomas, Chemical cross-linking of histones. Methods Enzymol 170, 549-571 (1989). 1078 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
16. M. Altaf et al., Interplay of chromatin modifiers on a short basic patch of histone H4 tail defines 1079 
the boundary of telomeric heterochromatin. Molecular cell 28, 1002-1014 (2007). 1080 
17. L. M. Johnson, P. S. Kayne, E. S. Kahn, M. Grunstein, Genetic evidence for an interaction 1081 
between SIR3 and histone H4 in the repression of the silent mating loci in Saccharomyces 1082 
cerevisiae. Proceedings of the National Academy of Sciences of the United States of America 87, 1083 
6286-6290 (1990). 1084 
18. A. Weiner et al., Systematic dissection of roles for chromatin regulators in a yeast stress 1085 
response. PLoS biology 10, e1001369 (2012). 1086 
19. A. P. Capaldi et al., Structure and function of a transcriptional network activated by the MAPK 1087 
Hog1. Nature genetics 40, 1300-1306 (2008). 1088 
20. A. P. Gasch et al., Genomic expression programs in the response of yeast cells to environmental 1089 
changes. Mol Biol Cell 11, 4241-4257 (2000). 1090 
21. D. K. Jha, B. D. Strahl, An RNA polymerase II-coupled function for histone H3K36 methylation in 1091 
checkpoint activation and DSB repair. Nature communications 5, 3965 (2014). 1092 
22. O. J. Rando, F. Winston, Chromatin and transcription in yeast. Genetics 190, 351-387 (2012). 1093 
23. B. D. Strahl et al., Set2 is a nucleosomal histone H3-selective methyltransferase that mediates 1094 
transcriptional repression. Molecular and cellular biology 22, 1298-1306 (2002). 1095 
24. M. J. Carrozza et al., Histone H3 methylation by Set2 directs deacetylation of coding regions by 1096 
Rpd3S to suppress spurious intragenic transcription. Cell 123, 581-592 (2005). 1097 
25. M. C. Keogh et al., Cotranscriptional set2 methylation of histone H3 lysine 36 recruits a 1098 
repressive Rpd3 complex. Cell 123, 593-605 (2005). 1099 
26. A. A. Joshi, K. Struhl, Eaf3 chromodomain interaction with methylated H3-K36 links histone 1100 
deacetylation to Pol II elongation. Molecular cell 20, 971-978 (2005). 1101 
27. C. K. Govind et al., Phosphorylated Pol II CTD recruits multiple HDACs, including Rpd3C(S), for 1102 
methylation-dependent deacetylation of ORF nucleosomes. Molecular cell 39, 234-246 (2010). 1103 
28. S. Drouin et al., DSIF and RNA polymerase II CTD phosphorylation coordinate the recruitment of 1104 
Rpd3S to actively transcribed genes. PLoS genetics 6, e1001173 (2010). 1105 
29. J. W. Huh et al., Multivalent di-nucleosome recognition enables the Rpd3S histone deacetylase 1106 
complex to tolerate decreased H3K36 methylation levels. The EMBO journal 31, 3564-3574 1107 
(2012). 1108 
30. C. J. Nelson, H. Santos-Rosa, T. Kouzarides, Proline isomerization of histone H3 regulates lysine 1109 
methylation and gene expression. Cell 126, 905-916 (2006). 1110 
31. M. L. Youdell et al., Roles for Ctk1 and Spt6 in regulating the different methylation states of 1111 
histone H3 lysine 36. Molecular and cellular biology 28, 4915-4926 (2008). 1112 
32. C. D. Kaplan, L. Laprade, F. Winston, Transcription elongation factors repress transcription 1113 
initiation from cryptic sites. Science (New York, N.Y 301, 1096-1099 (2003). 1114 
33. T. Suganuma, J. L. Workman, Crosstalk among Histone Modifications. Cell 135, 604-607 (2008). 1115 
34. W. S. Lo et al., Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in 1116 
vivo to Gcn5-mediated acetylation at lysine 14. Molecular cell 5, 917-926 (2000). 1117 
35. S. Liokatis, R. Klingberg, S. Tan, D. Schwarzer, Differentially Isotope-Labeled Nucleosomes To 1118 
Study Asymmetric Histone Modification Crosstalk by Time-Resolved NMR Spectroscopy. Angew 1119 
Chem Int Ed Engl 55, 8262-8265 (2016). 1120 
36. D. Segre, A. Deluna, G. M. Church, R. Kishony, Modular epistasis in yeast metabolism. Nature 1121 
genetics 37, 77-83 (2005). 1122 
37. S. A. Morris et al., Identification of histone H3 lysine 36 acetylation as a highly conserved histone 1123 
modification. The Journal of biological chemistry 282, 7632-7640 (2007). 1124 
38. C. C. Lechner, N. D. Agashe, B. Fierz, Traceless Synthesis of Asymmetrically Modified Bivalent 1125 
Nucleosomes. Angew Chem Int Ed Engl 55, 2903-2906 (2016). 1126 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
39. M. A. Shogren-Knaak, C. J. Fry, C. L. Peterson, A native peptide ligation strategy for deciphering 1127 
nucleosomal histone modifications. The Journal of biological chemistry 278, 15744-15748 1128 
(2003). 1129 
40. D. J. McKay et al., Interrogating the function of metazoan histones using engineered gene 1130 
clusters. Developmental cell 32, 373-386 (2015). 1131 
41. M. F. Dion et al., Dynamics of replication-independent histone turnover in budding yeast. 1132 
Science (New York, N.Y 315, 1405-1408 (2007). 1133 
42. J. Recht et al., Histone chaperone Asf1 is required for histone H3 lysine 56 acetylation, a 1134 
modification associated with S phase in mitosis and meiosis. Proceedings of the National 1135 
Academy of Sciences of the United States of America 103, 6988-6993 (2006). 1136 
43. H. Klinker, C. Haas, N. Harrer, P. B. Becker, F. Mueller-Planitz, Rapid purification of recombinant 1137 
histones. PloS one 9, e104029 (2014). 1138 
44. T. C. Miller et al., A bromodomain-DNA interaction facilitates acetylation-dependent bivalent 1139 
nucleosome recognition by the BET protein BRDT. Nature communications 7, 13855 (2016). 1140 
45. K. Luger, T. J. Rechsteiner, T. J. Richmond, Preparation of nucleosome core particle from 1141 
recombinant histones. Methods Enzymol 304, 3-19 (1999). 1142 
46. B. MacLean et al., Skyline: an open source document editor for creating and analyzing targeted 1143 
proteomics experiments. Bioinformatics 26, 966-968 (2010). 1144 
47. M. A. Collart, S. Oliviero, Preparation of yeast RNA. Curr Protoc Mol Biol Chapter 13, Unit13 12 1145 
(2001). 1146 
48. N. Morohashi et al., Effect of sequence-directed nucleosome disruption on cell-type-specific 1147 
repression by alpha2/Mcm1 in the yeast genome. Eukaryot Cell 5, 1925-1933 (2006). 1148 
49. S. G. Pattenden, M. M. Gogol, J. L. Workman, Features of cryptic promoters and their varied 1149 
reliance on bromodomain-containing factors. PloS one 5, e12927 (2010). 1150 
 1151 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/170811doi: bioRxiv preprint first posted online Jul. 31, 2017; 
